Julian Adams

Julian Adams, President and CEO of Stand Up To Cancer and a leading oncology researcher, shares insights on the transformative role of artificial intelligence in cancer detection. He discusses how AI enhances biopsy accuracy and early diagnosis, potentially leading to innovative treatments like therapeutic vaccines. Adams also explores advancements in liquid biopsies, improving cancer screening methods. The conversation highlights the evolution of patient-doctor interactions through technology, emphasizing the impact on healthcare outcomes.